Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- European journal of cancer (Oxford, England : 1990)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Piperazines; Phthalazines; Follow-Up Studies; Germ-Line Mutation; Genes, BRCA1; Genes, BRCA2; Physicians; Female; Erb-b2 Receptor Tyrosine Kinases; Breast cancer
- PubMed ID
- 36893711
- PubMed Central ID
- PMC10585240
- Open access
- Yes, free to read
- Added to directory
- Source checked